In the Litigation Daily article by Julie Triedman, "Supreme Court of Canada Rules for GlaxoSmithKline in Transfer-Pricing Case", Claire Kennedy comments on the Supreme Court decision that the Canadian government had to take into account more than just the narrow market price of a product when assessing whether GlaxoSmithKline's transfer pricing was reasonable.